Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontal Temporal Dementia”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Very early researchStudy completedNCT02531360
What this trial is testing

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Who this might be right for
Alzheimer's Disease (AD)Progressive Supranuclear Palsy (PSP)Cortical Basal Syndrome (CBS)+1 more
Molecular NeuroImaging 7
Not applicableEnded earlyNCT03052712
What this trial is testing

Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies

Who this might be right for
Alzheimer DiseaseParkinson DiseaseFrontal Dementia+3 more
Centre Hospitalier Universitaire, Amiens 44
Post-approval studies (Phase 4)Study completedNCT00545974
What this trial is testing

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

Who this might be right for
Frontal Lobe DementiaFrontotemporal Lobe DementiaSemantic Dementia
University of California, San Francisco 81
Testing effectiveness (Phase 2)Study completedNCT02118727
What this trial is testing

Therapy in Amyotrophic Lateral Sclerosis (TAME)

Who this might be right for
Amyotrophic Lateral SclerosisFrontal Temporal Dementia
University of Kansas Medical Center 89
Early research (Phase 1)Study completedNCT02103894
What this trial is testing

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Who this might be right for
Alzheimer's Disease (AD)Parkinson's Disease (PD)Chronic Traumatic Encephalopathy (CTE)+4 more
Molecular NeuroImaging 16